3D Signatures Inc. Announces Upsizing of $1,500,000 Private Placement, the Appointment of a New Director and Reports on AGM Results Pharmaceutical Investing
Nexalogy Enters into License and Development Agreement with Revive to Develop AI Component in Blockchain Enabled Patient-Focused Program Pharmaceutical Investing
Corbus Gets Patent Covering Use of Anabasum for the Treatment of Rare Fibrotic Diseases Pharmaceutical Investing
